Rosell, Johan
Nordenskjold, Bo
Bengtsson, Nils-Olof; et al.
|
Effects of adjuvant tamoxifen therapy on cardiac disease: results from a randomized trial with long-term follow-up
Breast Cancer Research and Treatment,
138(2): 467-473
|
2013
|
-
|
McGale, Paul
Darby, Sarah C.
Hall, Per; et al.
|
Incidence of heart disease in 35,000 women treated with radiotherapy for breast cancer in Denmark and Sweden
Radiotherapy and Oncology,
100(2): 167-175
|
2011
|
-
|
Chadda, S.
Larkin, M.
Jones, C.; et al.
|
The impact of infusion reactions associated with monoclonal antibodies in metastatic colorectal cancer: a european perspective
Value in Health,
14(3): A173-A173
|
2011
|
-
|
Edlund, Per
Ahlgren, Johan
Bjerre, Karsten; et al.
|
Dose-tailoring of FEC adjuvant chemotherapy based on leukopenia is feasible and well tolerated. Toxicity and dose intensity in the Scandinavian Breast Group phase 3 adjuvant Trial SBG 2000-1
Acta Oncologica,
50(3): 329-337
|
2011
|
-
|
Rosell, Johan
Nordenskjöld, B
Bengtsson, Nils-Olof; et al.
|
Time dependent effects of adjuvant tamoxifen therapy on cerebrovascular disease: results from a randomised trial
British Journal of Cancer,
104(6): 899-902
|
2011
|
-
|
Margolin, Sara
Bengtsson, Nils-Olof
Carlsson, Lena; et al.
|
A randomised feasibility/phase II study (SBG 2004-1) with dose-dense/tailored epirubicin, cyclophoshamide (EC) followed by docetaxel (T) or fixed dosed dose-dense EC/T versus T, doxorubicin and C (TAC) in node-positive breast cancer.
Acta Oncologica,
50(1): 35-41
|
2011
|
-
|
Sjöström-Mattson, Johanna
Von Boguslawski, Kristina
Bengtsson, Nils-Olof; et al.
|
The expression of p53, bcl-2, bax, fas and fasL in the primary tumour and lymph node metastases of breast cancer.
Acta oncologica (Stockholm, Sweden),
48(8): 1137-1143
|
2009
|
-
|
Villman, Kenneth
Sjöström, Johanna
Heikkilä, Reino; et al.
|
TOP2A and HER2 gene amplification as predictors of response to anthracycline treatment in breast cancer
Acta Oncol,
45(5): 590-596
|
2006
|
-
|
Ejlertsen, Bent
Mouridsen, Henning T
Jensen, Maj-Britt; et al.
|
Similar efficacy for ovarian ablation compared with cyclophosphamide, methotrexate, and fluorouracil: from a randomized comparison of premenopausal patients with node-positive, hormone receptor-positive breast cancer
J Clin Oncol,
24(31): 4956-4962
|
2006
|
-
|
Early Breast Cancer Trialists' Collaborative Group, EBCTCG
Bengtsson, Nils-Olof
Jonsson, Håkan; et al.
|
Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials.
The Lancet,
366(9503): 2087-2106
|
2005
|
-
|
